Showing posts with label generic pharmaceutical oral solid products. Show all posts
Showing posts with label generic pharmaceutical oral solid products. Show all posts

Friday, October 4, 2013

Pharmaceutical Industry Article: In vitro Dissolution Profile acts as a Pre-assessment Tool for Bioequivalence Study of Generic Pharmaceutical Oral Solid Products.

About Author: This article was Exclusively Written for Pharma Mirror Readers by Mohammad Dulal, Industrial Pharmacist licensed in MOH/Dubai, Senior Scientist, Product Development Lab, Julphar Gulf Pharmaceutical Ltd, Ras Al Khaimah, United Arab Emirates.
1.0 Introduction
Generic pharmaceutical products are clone of innovator products in the term of actives, strengths, dosage forms, dosage regimens and administrations. Actual fact is that innovator companies are very less in numbers in the world due to requirement of huge investment. Innovator companies are also not in good numbers enough to serve their medicines to all the worldwide patients. Reasonably, generic companies are established to serve their local patients with medicines at a manageable price. Generic companies cannot